AERIE PHARMACEUTICALS INC's ticker is AERI and the CUSIP is 00771V108. A total of 140 filers reported holding AERIE PHARMACEUTICALS INC in Q3 2021. The put-call ratio across all filers is 0.59 and the average weighting 0.1%.
Quarter-by-quarter ownership
Value | Shares | Weighting | ||||
---|---|---|---|---|---|---|
Q3 2022 | $30,000 | +76.5% | 2,000 | -13.0% | 0.00% | +100.0% |
Q2 2022 | $17,000 | -26.1% | 2,300 | -14.8% | 0.00% | 0.0% |
Q1 2022 | $23,000 | -11.5% | 2,700 | -93.6% | 0.00% | 0.0% |
Q4 2021 | $26,000 | -10.3% | 42,300 | +1526.9% | 0.00% | 0.0% |
Q3 2021 | $29,000 | -29.3% | 2,600 | 0.0% | 0.00% | -50.0% |
Q2 2021 | $41,000 | -10.9% | 2,600 | 0.0% | 0.00% | 0.0% |
Q1 2021 | $46,000 | +31.4% | 2,600 | 0.0% | 0.00% | 0.0% |
Q4 2020 | $35,000 | +2.9% | 2,600 | -10.3% | 0.00% | 0.0% |
Q3 2020 | $34,000 | -19.0% | 2,900 | 0.0% | 0.00% | -33.3% |
Q2 2020 | $42,000 | +7.7% | 2,900 | 0.0% | 0.00% | +50.0% |
Q1 2020 | $39,000 | -33.9% | 2,900 | -77.5% | 0.00% | -50.0% |
Q4 2019 | $59,000 | +43.9% | 12,900 | -20.9% | 0.00% | 0.0% |
Q3 2019 | $41,000 | +86.4% | 16,300 | +715.0% | 0.00% | +100.0% |
Q2 2019 | $22,000 | +22.2% | 2,000 | -44.4% | 0.00% | 0.0% |
Q1 2019 | $18,000 | -68.4% | 3,600 | -78.2% | 0.00% | -60.0% |
Q4 2018 | $57,000 | +23.9% | 16,500 | +57.1% | 0.01% | +66.7% |
Q3 2018 | $46,000 | -66.4% | 10,500 | -50.8% | 0.00% | -72.7% |
Q2 2018 | $137,000 | +315.2% | 21,320 | +82.2% | 0.01% | +266.7% |
Q1 2018 | $33,000 | -95.8% | 11,700 | -75.1% | 0.00% | -90.6% |
Q4 2017 | $782,000 | +161.5% | 47,042 | -12.4% | 0.03% | +166.7% |
Q3 2017 | $299,000 | -46.5% | 53,721 | -19.4% | 0.01% | -42.9% |
Q2 2017 | $559,000 | +168.8% | 66,617 | +70.4% | 0.02% | +162.5% |
Q1 2017 | $208,000 | -49.6% | 39,095 | -66.9% | 0.01% | -50.0% |
Q4 2016 | $413,000 | -79.6% | 118,240 | -58.7% | 0.02% | -82.4% |
Q3 2016 | $2,025,000 | +1018.8% | 286,040 | +1676.6% | 0.09% | +911.1% |
Q2 2016 | $181,000 | +166.2% | 16,100 | +119.0% | 0.01% | +125.0% |
Q1 2016 | $68,000 | -64.8% | 7,353 | -77.9% | 0.00% | -60.0% |
Q4 2015 | $193,000 | – | 33,312 | – | 0.01% | – |
Download |
Other shareholders
Name | Shares | Value | Weighting ↓ |
---|---|---|---|
Foresite Capital Management II, LLC | 906,317 | $16,078,000 | 4.88% |
Asymmetry Capital Management, L.P. | 85,834 | $1,523,000 | 3.39% |
March Altus Capital Management LP | 30,962 | $549,000 | 3.23% |
DAFNA Capital Management LLC | 165,669 | $2,939,000 | 2.92% |
Partner Investment Management, L.P. | 49,726 | $882,000 | 1.33% |
Boulegeris Investments, Inc. | 93,320 | $1,655,000 | 1.27% |
PFM Health Sciences, LP | 2,218,198 | $39,351,000 | 1.11% |
NORTHPOINTE CAPITAL LLC | 443,125 | $7,861,000 | 1.02% |
HARVEY CAPITAL MANAGEMENT INC | 121,850 | $2,161,000 | 0.86% |
Granite Point Capital Management, L.P. | 70,000 | $1,242,000 | 0.85% |